Management of febrile neutropaenia: ESMO Clinical Practice Guidelines

被引：484
作者：
Klastersky, J. [1 ]
de Naurois, J. [2 ]
Rolston, K. [3 ]
Rapoport, B. [4 ]
Maschmeyer, G. [5 ]
Aapro, M. [6 ]
Herrstedt, J. [7 ]
机构：
[1] ULB, Inst Jules Bordet, Ctr Tumeurs, Brussels, Belgium
[2] Royal Surrey Cty Hosp, St Lukes Canc Ctr, Guildford, Surrey, England
[3] Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USA
[4] Med Oncol Ctr Rosebank, Johannesburg, South Africa
[5] Ernst von Bergmann Hosp, Dept Hematol Oncol & Palliat Care, Potsdam, Germany
[6] Clin Genolier, Multidisciplinary Inst Oncol, Genolier, Switzerland
[7] OUH, Dept Oncol, Odense, Denmark
来源：
ANNALS OF ONCOLOGY | 2016年 / 27卷
关键词：
COLONY-STIMULATING FACTORS; CANCER-PATIENTS; MULTINATIONAL-ASSOCIATION; PRIMARY PROPHYLAXIS; SUPPORTIVE-CARE; AMPHOTERICIN-B; DOUBLE-BLIND; RISK INDEX; CHEMOTHERAPY; THERAPY;
D O I：
10.1093/annonc/mdw325
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
[No abstract available]
引用
收藏
页码：v111 / v118
页数：8
相关论文
共 34 条
[1]   2010 update of EORTC guidelines for the use of granulocyte-colony stimulating factor to reduce the incidence of chemotherapy-induced febrile neutropenia in adult patients with lymphoproliferative disorders and solid tumours [J].
Aapro, M. S. ;
Bohlius, J. ;
Cameron, D. A. ;
Dal Lago, Lissandra ;
Donnelly, J. Peter ;
Kearney, N. ;
Lyman, G. H. ;
Pettengell, R. ;
Tjan-Heijnen, V. C. ;
Walewski, J. ;
Weber, Damien C. ;
Zielinski, C. .
EUROPEAN JOURNAL OF CANCER, 2011, 47 (01) :8-32
[2]  
[Anonymous], COCHRANE DATABASE SY
[3]   Colony-stimulating factors for chemotherapy-induced febrile neutropenia: A meta-analysis of randomized controlled trials [J].
Clark, OAC ;
Lyman, GH ;
Castro, AA ;
Clark, LGO ;
Djulbegovic, B .
JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (18) :4198-4214
[4]   Granulocyte colony-stimulating factors for febrile neutropenia prophylaxis following chemotherapy: systematic review and meta-analysis [J].
Cooper, Katy L. ;
Madan, Jason ;
Whyte, Sophie ;
Stevenson, Matt D. ;
Akehurst, Ron L. .
BMC CANCER, 2011, 11
[5]   Liposomal amphotericin B as initial therapy for invasive mold infection: A randomized trial comparing a high-loading dose regimen with standard dosing (AmBiLoad trial) [J].
Cornely, Oliver A. ;
Maertens, Johan ;
Bresnik, Mark ;
Ebrahimi, Ramin ;
Ullmann, Andrew J. ;
Bouza, Emilio ;
Heussel, Claus Peter ;
Lortholary, Olivier ;
Rieger, Christina ;
Boehme, Angelika ;
Aoun, Mickael ;
Horst, Heinz-August ;
Thiebaut, Anne ;
Ruhnke, Markus ;
Reichert, Dietmar ;
Vianelli, Nicola ;
Krause, Stefan W. ;
Olavarria, Eduardo ;
Herbrecht, Raoul .
CLINICAL INFECTIOUS DISEASES, 2007, 44 (10) :1289-1297
[6]   Summary of the guidelines for preventing opportunistic infections among hematopoietic stem cell transplant recipients [J].
Dykewicz, CA .
CLINICAL INFECTIOUS DISEASES, 2001, 33 (02) :139-144
[7]   Outcomes and cost of outpatient or inpatient management of 712 patients with febrile neutropenia [J].
Elting, Linda S. ;
Lu, Charles ;
Escalante, Carmelita P. ;
Giordano, Sharon H. ;
Trent, Jonathan C. ;
Cooksley, Catherine ;
Avritscher, Elenir B. C. ;
Shih, Ya-Chen Tina ;
Ensor, Joe ;
Bekele, B. Nebiyou ;
Gralla, Richard J. ;
Talcott, James A. ;
Rolston, Kenneth .
JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (04) :606-611
[8]   Bloodstream infections in cancer patients with febrile neutropenia [J].
Feld, Ronald .
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 2008, 32 :S30-S33
[9]   A double-blind comparison of empirical oral and intravenous antibiotic therapy for low-risk febrile patients with neutropenia during cancer chemotherapy [J].
Freifeld, A ;
Marchigiani, D ;
Walsh, T ;
Chanock, S ;
Lewis, L ;
Hiemenz, J ;
Hiemenz, S ;
Hicks, JE ;
Gill, V ;
Steinberg, SM ;
Pizzo, PP .
NEW ENGLAND JOURNAL OF MEDICINE, 1999, 341 (05) :305-311
[10]   Monotherapy or aminoglycoside-containing combinations for empirical antibiotic treatment of febrile neutropenic patients: a meta-analysis [J].
Furno, P ;
Bucaneve, G ;
Del Favero, A .
LANCET INFECTIOUS DISEASES, 2002, 2 (04) :231-242
1234